The objective for this study was to explore if characteristics of personality type using the Preferred Communication Style Questionnaire, in concert with the demographic characteristics of age, education, and race/ethnicity, are associated with, and help predict, individuals' medication adherence behavior. States, between April 28 and June 22, 2015. Out of 26,173 
The findings showed that an Adherence Predictive Index (API) could be developed based upon a relatively small number of questions that focus on personality type and generational, educational, and cultural experiences. It was developed in order to be a component of a comprehensive program that has the goals of (1) identifying and describing specific behavioral strategies individuals are most likely to successfully employ, (2) motivating patients by using their preferred communication style, and (3) predicting each patient's propensity to adhere. Future research is needed to evaluate the index's validity, sensitivity, and effectiveness in actual practice compared with other risk indices.

Medication Adherence
Adherence is the term currently used most often in healthcare to describe a patient's ability and willingness to follow a healthcare provider's recommendations [1] . This definition suggests that patients perform an important role for maintaining their health by making decisions and engaging in prescribed behaviors [2, 3] . A significant proportion of negative health outcomes and the estimated $290 billion dollar annual cost resulting from poor medication adherence is avoidable [4] [5] [6] [7] . One of the first steps in promoting adherent behaviors is building an individualized, positive patient-provider relationship [8] [9] [10] . Just as precision medicine recognizes that optimal clinical outcomes require differentiation according to a patient's genetic and molecular make-up [11] , it follows that achieving optimal health outcomes must recognize differentiation according to a patient's preferences for the delivery and use of health care [8] [9] [10] . For example, providers must be able to give health information in a clear manner to diverse populations with varying backgrounds and dispositions. Research has shown that conveying empathy and warmth to some patients can positively impact patient trust and satisfaction with providers and can lead to higher levels of adherence [12] .
Patient-Centered, Personalized Medication Adherence
Patients hold patient-centered viewpoints of medication use based on their personal expectations and life experiences [13] . This differs from prescribers, pharmacists, and patient advocates who apply healthcare-centered viewpoints based upon their professional training and experience [13] . That is, a patient's experience with medication is more than a clinical experience … it is a social and personal experience. Typically, the health care system views patients' experiences with medications in terms of clinical problem-solving (prescribing, monitoring, reconciling) and in terms of medication regimen adherence (i.e. following directions) [14] . Research has shown that a patient's experiences with medications are rooted in medication beliefs, personal abilities and motivations, information processing, decision-making, relationships, finances, and the effects of life experiences [13] [14] [15] [16] [17] [18] [19] . Patients vary widely in their make-up, their preferences, and their needs. Some patients don't want to receive any information from others about their medications while others desire to take an active role in making decisions about them [13, 14] . Some people want information about effects of medications, but others want to know about safety. In addition, when people seek information about medicines, there is a high likelihood that they will involve a personal contact, either lay or professional, in their search [15] [16] [17] [18] [19] . This all underlines the importance of social networks in the decisions people make about prescription drugs. Patients have different abilities, motivations, and needs when it comes to medication use. The challenge, then, is to meet the unique needs, preferences, and styles of each individual.
Personality Type and Adherence
These findings suggest that medication adherence likely is associated with (1) the kind of information people naturally notice, (2) how they make decisions, and (3) whether they prefer to live in a more structured way or in a more spontaneous way, all of which are associated with personality type [20] [21] [22] [23] . The Personality Type construct reflects innate, individual characteristics and is applicable to this study since medication adherence has been shown to be affected by information processing, decision-making, and life preferences of patients [13] [14] [15] [16] [17] [18] [19] . As mentioned before, a patient's experience with medication is more than a clinical experience … it is a social and personal experience. The personality type construct used in this study (called the Preferred Communication Style Questionnaire) focused on what kind of information people naturally notice and remember, how they make decisions, and how they like to organize the world around them. The assumption for this study is that personality type can be used for developing an "adherence predictive index" (API) for medication taking since it characterizes important personal characteristics that are associated with the likelihood of medication adherence.
Study Objective
Ideally, the adherence predictive index (API) would be a tool that could be applied before a patient begins a medication regimen so that pharmacists, prescribers, and other healthcare providers could identify the likelihood of each individual patient's medication adherence using simple questions. Furthermore, the ideal API would not require any prior experiences with medications on the part of the patient. By focusing on the kind of information people naturally notice, how they make decisions, whether they prefer to live in a more structured way or in a more spontaneous way, generational experiences, educational experiences, and cultural experiences, it is proposed that the resultant API can help guide strategies for: (1) identifying and describing specific behavioral strategies individuals are most likely to successfully employ, (2) motivating patients by employing their preferred personality type, and (3) predicting each patient's propensity to adhere. Thus, the objective for this study was to explore if characteristics of personality type (using the Preferred Communication Style Questionnaire), in concert with the demographic factors of age, education, and race/ethnicity, may be associated with, and help predict, individuals' adherence behavior.
Methods
Study Variables
Tieger and colleagues developed and validated the Preferred Communication Style Questionnaire as a way to measure the specific characteristics of a persons' personality type [22, 23] . Questions in that questionnaire relate to (1) the kind of information people naturally notice, (2) how people make decisions, and (3) whether people prefer to live in a more structured way or in a more spontaneous way. In addition to personality type and the three demographic variables (age, education, and race/ethnicity), one medication adherence behavior measure was used for this study. This behavioral measure was used for developing the Adherence Predictive Index (API) as described in the "Data Analysis and Development of the Adherence Predictive Index" section.
The measure of medication adherence used for this study was the Morisky Medication Adherence Scale (MMAS-8) [25] [26] [27] [28] . This eight-item measure was adopted with permission (refer to Appendix B). The potential range of scores on the MMAS-8 is from 0 to 8 (see Appendix B). A score of 0 is considered "high adherence", with scores of greater than 0 but less than 3 "medium adherence", and scores of 3-8 "low adherence". Data Analysis and Development of the Adherence Predictive Index Descriptive statistics were computed for all study variables. Linear regression analysis was conducted to describe the associations between the three questions used to measure personality type, age, education, and race/ethnicity with the raw medication adherence score (MMAS-8 that has a range from 0 to 8). Linear regression was conducted in an exploratory and comparative manner even though the distribution of MMAS-8 scores was not normal and linear regression is not typical for analysis of MMAS-8 scores.
Linear regression provided evidence to use in decisionmaking related to the development of the Adherence Predictive Index (API).
In addition to linear regression, the more typical logistic regression analysis was completed to describe the associations between the eight personality type categories, age, education, and race/ethnicity with a dichotomized score for medication adherence (1 = MMAS-8 score from 3 to 8 considered to be low adherence and 0 = MMAS-8 score less than 3 considered to be moderate to high adherence). These analyses were completed to verify associations among the variables and also to help guide decisions about weighting for these variables as they were utilized for development of the Adherence Predictive Index (API).
The development of the Adherence Predictive Index (API) used mean MMAS-8 scores for each of the eight personality types as a starting point. API scores were calculated from this starting point by adding or subtracting specific values to the mean MMAS-8 score based on personality type, age, education and race/ethnicity characteristics which were demonstrated to have significant effects on adherence. The weighting system was informed by linear regression, logistic regression, personality type literature, researcher experience, and previous qualitative and quantitative research conducted by Tieger [22, 23] . After the weighting was completed, the resultant score was converted to an API score that would be feasible for health care providers to understand and use.
Results
Descriptive Findings
Descriptive results for personality type, age, education, and race/ethnicity are summarized in Table 2 The measure of medication adherence (MMAS-8) ranged from 0 to 8 with a median equal to 2.25 and mode equal to 0 (21% of respondents had scores equal to 0). The mean score was 2.4 with a standard deviation equal to 2.0. Of the 16,736 respondents, 6,483 (39%) reported MMAS-8 scores from 3 to INNOVATIONS in pharmacy 4 8 (low adherence) and 10,253 (61%) reported moderate to high adherence (scores less than 3.0). Linear Regression and Logistic Regression As described in the Methods section, linear and logistic regression analyses were conducted to describe statistically significant associations among study variables with the outcome of interest (medication adherence). Linear regression used the raw adherence score (range 0 to 8).
Findings from this analysis are presented in Table 3 . Findings from both the linear and logistic regression analysis revealed consistent patterns. Age was associated the strongest with medication adherence followed by: personality type (specifically the Judging or Perceiving characteristic), Race/Ethnicity, and Education. These patterns of findings, combined with personality type literature, researcher experience, and previous qualitative and quantitative researcher conducted by Tieger and colleagues [22, 23] , were used to develop the Adherence Predictive Index (API).
The Adherence Predictive Index (API) The development of the Adherence Predictive Index (API) used mean MMAS-8 scores for each of the eight personality types as a starting point. API scores were calculated from this starting point by adding or subtracting specific values to the mean MMAS-8 score based on personality type, age, education and race/ethnicity characteristics which were demonstrated to have significant effect on adherence. The weighting system was informed by linear regression, logistic regression, personality type literature, researcher experience, and previous qualitative and quantitative research conducted by Tieger and colleagues [22, 23] .
Variables that positively affected self-reported medication adherence were: having more education, being white, being 70 years of age or older, and having a "Judging" personality type preference. Variables that negatively affected selfreported medication adherence were: having less education, being non-white, and having a "Perceiving "personality type preference. Since a higher MMAS-8 score in the scoring system used in this study was associated with lower adherence, the following weights were applied:
• 0.3 was added for subjects with less than a bachelor's degree education • 0.3 was added for non-white subjects • 0.5 was subtracted if the subject was 70 years of age or older • 0.3 was subtracted if the subject had a personality preference for "Judging"
To improve the usability of the index, the resultant scores were converted to a 1 to 5 scale with 1 being the lowest score (least adherent) and 5 being the highest (most adherent). The following conversion 
Scores were computed for each of the 128 combinations that resulted from eight personality type categories, four age categories, two education categories and two race/ethnicity categories (8 x 4 x 2 x 2 = 128). Findings are summarized in Table 5 .
The findings show that the most adherent STJs are educated, white Pre 1946'ers, followed by less educated, white Pre 1946'ers. The least adherent STJs are less educated, nonwhite Millennials and Boomers. Higher API scores corresponded to increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent SFJs are educated, white Pre 1946'ers, the least adherent SFJs are less educated, non-white Millennials.
Higher API scores corresponded with increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent STPs are educated, white Pre 1946'ers, the least adherent STPs are educated, non-white Millennials. Higher API scores corresponded to increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent SFPs are less-educated, white Pre 1946'ers, the least adherent SFPs are less educated, nonwhite Millennials. Higher API scores corresponded with increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent NTJs are educated, white Pre 1946'ers, the least adherent NTJs are less-educated non-white X'ers. Higher API scores corresponded to increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent NTPs are educated, white Pre 1946'ers, the least adherent NTPs are educated, non-white Millennials.
Higher API scores corresponded to increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent NFJs are less educated, white Pre 1946'ers, the least adherent NFJs are less and more educated non-white Millennials. Higher API scores corresponded to increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
The most adherent NFPs educated, white Pre 1946'ers, the least adherent NFPs are less-educated, non-white Millennials. Higher API scores corresponded to increased age of subjects. The relatively low Ns for non-white Pre 1946'ers is probably due to the lack of educational opportunity and necessity of obtaining a college degree at the time these subjects were college age.
Discussion and Conclusions
Before the findings are discussed, limitations of the study should be noted. First, some of the cells in Table 5 for which API scores were computed have sizes less than 30. While most of the cells are robust from a sample size perspective, the cells with relatively small sample sizes should be interpreted with caution. Second, respondents to the survey were part of a panel and may not be representative of the whole United States adult population. Overall the respondents in this study were matched well in terms of geographic location and age. However, the proportion of female respondents was higher than the U.S. population census estimate. The goal of this study was not to make population estimates. Rather the goal was to use the data to develop a tool that could be used for improving patient care. If population estimates were of interest, weighting of the data to match the population of interest would be needed. Third, the Adherence Predictive Index was developed based upon self-reported medication adherence (MMAS-8) and not on actual behavior data. It is possible that self-reports are biased. However, the MMAS-8 is widely accepted as reliable and valid for the purposes of this study. It should be noted that a relatively large group of respondents (21%) had MMAS-8 scores of zero (high adherence). This is a reasonable finding since respondents in this study were from the general population and took varied, often simple drug regimens. This is in contrast to application of the MMAS-8 in other studies that often are focused on patient populations using specific medications for a single disease. Finally, the application of personality type has limitations such as the amount of variance explained and applicability in certain situations [30] [31] [32] . We acknowledge these limitations and were careful to apply a personality type measure (Preferred Communication Style Questionnaire) that had direct relevance to medication adherence.
Overall, the findings described the development of the Adherence Predictive Index (API) that was built upon personality type, a self-reported adherence measure, and demographic variables. It should be noted that the application of the MMAS-8 measure in this study was novel in that it was used for development of the API. Henceforth, the computation of the API only requires relatively few questions of patients (three personality type questions, plus information about the person's age, education, and race/ethnicity). Thus, the API can be applied before a patient begins a medication regimen and can help predict the likelihood of adherence. This can help identify patients a priori who may need assistance in order to achieve good medication adherence. This approach is in contrast to other adherence estimators that rely on the need to (1) know patients' past adherence behavior, (2) measure patients' perceptions about medications after they are prescribed or taken, or (3) have access to proprietary medical records or claims data in order to conduct predictive analytics [33] [34] [35] .
The Adherence Predictive Index (API) can have great practical value for pharmacists, prescribers, and other healthcare providers by identifying the likelihood of each individual patient's medication adherence using simple questions. The utility of the API is that it can be used as a predictive tool without any prior knowledge about a person's past medication adherence behaviors and without any prior experiences with medications on the part of the patient. The focus of the API is on patient-centered information (the kind of information people naturally notice, how they make decisions, whether they prefer to live in a more structured way or in a more spontaneous way, generational experiences, educational experiences, and cultural experiences). Furthermore, the API can help guide strategies for: (1) identifying and describing specific behavioral strategies individuals are most likely to successfully employ, (2) motivating patients by employing their preferred personality type, and (3) predicting each patient's propensity to adhere.
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Future research is needed to evaluate the index's validity, sensitivity, and effectiveness in actual practice compared with other risk indices. Logistic regression used a dichotomized measure of medication adherence (1 = MMAS-8 score from 3 to 8 considered to be low adherence and 0 = MMAS-8 score less than 3 considered to be moderate to high adherence). Logistic regression findings are summarized in Table 4 . .001 * (1 = MMAS-8 score from 3 to 8 considered to be low adherence and 0 = MMAS-8 score less than 3 considered to be moderate to high adherence) * signifies comparison group 
